Mylan Launches First Generic Targretin Capsules

Mylan Launches First Generic Targretin Capsules
Mylan Launches First Generic Targretin Capsules

Mylan announced the launch of Bexarotene capsules, the generic version of Valeant's Targretin Capsules.

Targretin is a retinoid indicated for the treatment of cutaneous manifestations of cutaneous t-cell lymphoma in patients who are refractory to at least one prior systemic therapy. Bexarotene selectively binds and activates retinoid X receptor subtypes (RXRa, RXRb, RXRg). It inhibits the growth in vitro of some tumor cell lines of hematopoietic and squamous cell origin. It also induces tumor regression in vivo in some animal models.

RELATED: Mylan Launches Generic Seasonique

Bexarotene is available as 75mg strength capsules.

For more information call (800) RX-MYLAN or visit Mylan.com.